Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Zacks Investment Research
AFYA or UTI: Which Is the Better Value Stock Right Now?A comparison of two education stocks shows Afya (AFYA) presents a better value opportunity than Universal Technical Institute (UTI). Afya has a stronger Zacks Rank of #2 (Buy) versus UTI's #3 (Hold), and significantly better valuation metrics including a forward P/E of 7.54 compared to UTI's 26.85, earning Afya an A Value grade versus UTI's C grade.
Zacks Investment Research
Should Value Investors Buy Afya (AFYA) Stock?Zacks identifies Afya (AFYA) as an attractive value investment opportunity, citing its Zacks Rank #2 (Buy) rating and 'A' grade for Value. The stock trades at a P/E ratio of 8.67, below its industry average of 10.74, with favorable PEG, P/B, and P/CF ratios suggesting undervaluation relative to its earnings growth prospects.
Headlines open the publisher's site.
